The Department of Medicine's Division of Rheumatology at the University of Massachusetts Medical School provides comprehensive care for patients with rheumatic diseases and is heavily involved in medical education and clinical research.This collection showcases journal articles and other publications and presentations written by faculty and researchers of the Division of Rheumatology.
Publications from 2018
Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis, Charles Birbara, Eugene J. Dabezies Jr, Aimee M. Burr, Robert J. Fountaine, Michael D. Smith, Mark T. Brown, Christine R. West, Rosalin H. Arends, and Kenneth M. Verburg
Methods for high-dimensonal analysis of cells dissociated from cyropreserved synovial tissue, Laura T. Donlin, Ellen M. Gravallese, and Jennifer H. Anolik
Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies, Dafna D. Gladman, Arthur Kavanaugh, Juan J. Gomez-Reino, Jurgen Wollenhaupt, Maurizio Cutolo, Georg Schett, Eric Lespessailles, Benoit Guerette, Nikolay Delev, Lichen Teng, Christopher J. Edwards, Charles Birbara, and Philip J. Mease
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation, Shahrad Hakimian, Yevgeniy Popov, Abbas Rupawala, Karen I. Salomon-Escoto, Steven Hatch, and Randall Pellish
Towards an arthritis flare-responsive drug delivery system, Nitin Joshi, Ellen M. Gravallese, Joerg Ermann, and Jeffrey M. Karp
Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation, Purvi Mande, Bahar Zirak, Wei-Che Ko, Keyon Taravati, Karen L. Bride, Tia Bumpus Brodeur, April C. Deng, Karen A. Dresser, Zhaozhao Jiang, Rachel Ettinger, Katherine A. Fitzgerald, Michael D. Rosenblum, John E. Harris, and Ann Marshak-Rothstein
Publications from 2017
STING Contributes to Abnormal Bone Formation Induced by Deficiency of DNase II in Mice, Rebecca Baum, Shrutie Sharma, Jason M. Organ, Christopher Jakobs, Veit Hornung, David B. Burr, Ann Marshak-Rothstein, Katherine A. Fitzgerald, and Ellen M. Gravallese
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis, Juergen Braun and Jonathan Kay
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial, Gerd R. Burmester, William F. Rigby, Ronald F. van Vollenhoven, Jonathan Kay, Andrea Rubbert-Roth, Ricardo Blanco, Alysha Kadva, and Sophie Dimonaco
Biosimilars: implications for rheumatoid arthritis therapy, Stanley Cohen and Jonathan Kay
Autoreactive helper T cells alleviate the need for intrinsic TLR signaling in autoreactive B cell activation, Josephine R. Giles, Adriana Turqueti Neves, Ann Marshak-Rothstein, and Mark J. Shlomchik
Clinical trials of biosimilars should become more similar, Jonathan Kay and John D. Isaacs
Synovium-Derived MicroRNAs Regulate Bone Pathways in Rheumatoid Arthritis, Yukiko Maeda, Nicholas H. Farina, Melissa M. Matzelle, Paul J. Fanning, Jane B. Lian, and Ellen M. Gravallese
Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent, Sudesh Pawaria, Shrutie Sharma, Rebecca Baum, Kerstin Nundel, Patricia Busto, Ellen M. Gravallese, Katherine A. Fitzgerald, and Ann Marshak-Rothstein
What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions, Sophi Tatlock, Katja Rudell, Charlotte Panter, Rob Arbuckle, Leslie R. Harrold, William J. Taylor, and Tara Symonds
c-Jun N-terminal kinases (JNKs) are critical mediators of osteoblast activity in vivo, Ren Xu, Chao Zhang, Dong Yeon Shin, Jung-Min Kim, Sarfaraz Lalani, Na Li, Yeon-Suk Yang, Yifang Liu, Mark Eiseman, Roger J. Davis, Jae-Hyuck Shim, and Matthew B. Greenblatt
Publications from 2016
Synergy between Hematopoietic and Radioresistant Stromal Cells Is Required for Autoimmune Manifestations of DNase II-/-IFNaR-/- Mice, Rebecca Baum, Kerstin Nundel, Sudesh Pawaria, Shrutie Sharma, Patricia Busto, Katherine A. Fitzgerald, Ellen M. Gravallese, and Ann Marshak-Rothstein
Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry, Jeffrey R. Curtis, Aseem Bharat, Lang Chen, Jeffrey D. Greenberg, Leslie R. Harrold, Joel M. Kremer, Tanya Sommers, and Dimitrios Pappas
The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis, Atul Deodhar, Vibeke Strand, Jonathan Kay, and Juergen Braun
The changing landscape of biosimilars in rheumatology, Thomas Dorner, Vibeke Strand, Paul Cornes, Joao Goncalves, Laszlo Gulacsi, Jonathan Kay, Tore K. Kvien, Josef S. Smolen, Yoshiya Tanaka, and Gerd R. Burmester
Brief Report: Development and Validation of a Semiautomated Method to Measure Erosion Volume in Inflammatory Arthritis by Computed Tomography Scanning, Jeffrey Duryea, Ruby Russell, Ellen M. Gravallese, Jonathan Kay, Roger Han, Bing Lu, and Daniel H. Solomon
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3), Christopher J. Edwards, Francisco J. Blanco, Jeffrey Crowley, Charles Birbara, Janusz Jaworski, Jacob Aelion, Randall M. Stevens, Adele Vessey, Xiaojiang Zhan, and Paul Bird
Differential Expression of Hedgehog and Snail in Cutaneous Fibrosing Disorders: Implications for Targeted Inhibition, Amrita Goyal, Katy R. Linskey, Jonathan Kay, Lyn M. Duncan, and Rosalynn M. Nazarian
Control of the innate immune response by the mevalonate pathway, Zhaozhao Jiang, Celia E. Foster, Annie S. Li, Xiaoman Zhang, Ruth M. Gavin, Sorcha D. Forde, Gail Germain, Susan B. Carpenter, Neal S. Silverman, Ellen M. Gravallese, Katherine A. Fitzgerald, Douglas T. Golenbock, and Donghai Wang
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein, and Jurgen Braun
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein, and Jurgen Braun
Objectively Measured Physical Activity and Symptoms Change in Knee Osteoarthritis, Shao-Hsien Liu, Jeffrey B. Driban, Charles Eaton, Timothy McAlindon, Leslie R. Harrold, and Kate L. Lapane
Inflammation in arthritis induces expression of BMP3, an inhibitor of bone formation, Melissa M. Matzelle, A. T. Shaw, Rebecca Baum, Yukiko Maeda Garrison, J. Li, S. Karmakar, Catherine A. Manning, N. C. Walsh, V. Rosen, and Ellen M. Gravallese
RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis, William O'Brien, Brian M. Fissel, Yukiko Maeda Garrison, Jing Yan, Xianpeng Ge, Ellen M. Gravallese, Antonios O. Aliprantis, and Julia F. Charles
Endothelial-specific inhibition of NF-kappaB enhances functional haematopoiesis, Michael G. Poulos, Pradeep Ramalingam, Michael C. Gutkin, Maria Kleppe, Michael Ginsberg, Michael J. P. Crowley, Olivier Elemento, Ross L. Levine, Shahin Rafii, Jan Kitajewski, Matthew B. Greenblatt, Jae-Hyuck Shim, and Jason M. Butler
Imaging for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome, Steven Schaub, Hartley M. Sirkis, and Jonathan Kay
Mediators of inflammation and bone remodeling in rheumatic disease, Anita T. Shaw and Ellen M. Gravallese
IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis, Anita T. Shaw, Yukiko Maeda, and Ellen M. Gravallese
Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis, Zheni Stavre, Katherine S. Upchurch, Jonathan Kay, and Ellen M. Gravallese
Gadolinium-Induced Fibrosis, Derrick J. Todd and Jonathan Kay
The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016, Kevin Winthrop and Jonathan Kay
Publications from 2015
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts, Rebecca Baum and Ellen M. Gravallese
Cutting Edge: AIM2 and Endosomal TLRs Differentially Regulate Arthritis and Autoantibody Production in DNase II-Deficient Mice, Rebecca Baum, Shrutie Sharma, Susan Carpenter, Quan-Zhen Li, Patricia Busto, Katherine A. Fitzgerald, Ann Marshak-Rothstein, and Ellen M. Gravallese
Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis, D. A. Binks, Ellen M. Gravallese, D. Bergin, R. J. Hodgson, A. L. Tan, Melissa M. Matzelle, D. McGonagle, and A. Radjenovic
Detection of IgG4-Specific Autoantibodies in Rheumatoid Arthritis Serum Samples, Azra Borogovac, Youmna Lahoud, Janice Weaver, Sheldon M. Cooper, Mercedes Rincon, Jonathan Kay, and Ellen M. Gravallese
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial, Gerd R. Burmester, William F. Rigby, Ronald F. van Vollenhoven, Jonathan Kay, Andrea Rubbert-Roth, Ariella Kelman, Sophie Dimonaco, and Nina Mitchell
Biosimilars in rheumatology: what the clinician should know, Gilberto Castaneda-Hernandez, Rodrigo Gonzalez-Ramirez, Jonathan Kay, and Morton A. Scheinberg
Biosimilars in rheumatology: current perspectives and lessons learnt, Thomas Dorner and Jonathan Kay
Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model, Pierre Duffau, Hanni Menn-Josephy, Carla M. Cuda, Salina Dominguez, Tamar R. Aprahamian, Amanda A. Watkins, Kei Yasuda, Paul Monach, Robert Lafyatis, Lisa M. Rice, G. Kenneth Haines 3rd., Ellen M. Gravallese, Rebecca Baum, Christophe Richez, Harris Perlman, Ramon G. Bonegio, and Ian R. Rifkin
Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry, Leslie R. Harrold, George W. Reed, Ashwini Shewade, Robert P. Magner, Katherine Saunders, Ani John, Joel M. Kremer, and Jeffrey D. Greenberg
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis, Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Michael Mack, Neil Goldstein, Jurgen Braun, and Arthur Kavanaugh
Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy, Zhanguo Li, Fengchun Zhang, Jonathan Kay, Kaiyin Fei, Chenglong Han, Yanli Zhuang, Zhong Wu, and Elizabeth C. Hsia
Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium, H. Matsumoto, Y. Murakami, K. Kataoka, S. Notomi, D. Mantopoulos, G. Trichonas, J. W. Miller, M. S. Gregory, B R. Ksander, Ann Marshak-Rothstein, and D. G. Vavvas
Overcoming adherence issues and other barriers to optimal care in gout, Navine Nasser-Ghodsi and Leslie R. Harrold
Quality indicators in rheumatoid arthritis: results from the METEOR database, Victoria Navarro-Compan, Josef S. Smolen, Tom Huizinga, Robert Landewe, Gianfranco Ferraccioli, Jose A.P. da Silva, Robert J. Moots, Jonathan Kay, and Desiree van der Heijde
An unexpected role for RNA-sensing toll-like receptors in a murine model of DNA accrual, Sudesh Pawaria, Krishna L. Moody, Patricia Busto, Kerstin Nundel, Rebecca Baum, Shrutie Sharma, Ellen M. Gravallese, Katherine A. Fitzgerald, and Ann Marshak-Rothstein
Suppression of systemic autoimmunity by the innate immune adaptor STING, Shrutie Sharma, Allison M. Campbell, Jennie Chan, Stefan A. Schattgen, Gregory M. Orlowski, Ribhu Nayar, Annie H. Huyler, Kerstin Nundel, Chandra Mohan, Leslie J. Berg, Mark J. Shlomchik, Ann Marshak-Rothstein, and Katherine A. Fitzgerald
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor inverted question mark inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study, Josef S. Smolen, Jonathan Kay, Mittie Doyle, Robert Landewe, Eric L. Matteson, Norman Gaylis, Jurgen Wollenhaupt, Frederick T. Murphy, Stephen Xu, Yiying Zhou, and Elizabeth C. Hsia
Publications from 2014
Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy, Herbert S. B. Baraf, Robert A. Yood, Faith D. Ottery, John S. Sundy, and Michael A. Becker
Impact of inflammation on the osteoblast in rheumatic diseases, Rebecca Baum and Ellen M. Gravallese
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study, Elana J. Bernstein, Tamara Isakova, Mary E. Sullivan, Lori B. Chibnik, Myles Wolf, and Jonathan Kay
Current status of nephrogenic systemic fibrosis, L. Daftari Besheli, S. Aran, K. Shaqdan, Jonathan Kay, and H. Abujudeh
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Maxime Dougados, Martin Soubrier, Anna Antunez, Peter Balint, Alejandro Balsa, Maya H. Buch, Gustavo Casado, Jacqueline Detert, Bassel El-Zorkany, Paul Emery, Najia Hajjaj-Hassouni, Masayoshi Harigai, Shue-Fen Luo, Reka Kurucz, Gabriel Maciel, Emilio Martin Mola, Carlo Maurizio Montecucco, Iain McInnes, Helga Radner, Josef S. Smolen, Yeong-Wook Song, Harald Erwin Vonkeman, Kevin Winthrop, and Jonathan Kay
Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant, Anand Dusad, Michael J. Duryee, Anita T. Shaw, Lynell W. Klassen, Daniel R. Anderson, Dong Wang, Ke Ren, Ellen M. Gravallese, James R. O'Dell, Ted R. Mikuls, and Geoffrey M. Thiele
Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year, Jonathan Kay, Olga Morgacheva, Susan P. Messing, Joel M. Kremer, Jeffrey D. Greenberg, George W. Reed, Ellen M. Gravallese, and Daniel E. Furst
Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis, Seung-Jae Kim, Zhenlong Chen, Nathan D. Chamberlain, Abdul B. Essani, Michael V. Volin, M. Asif Amin, Suncica Volkov, Ellen M. Gravallese, Shiva Arami, William Swedler, Nancy E. Lane, Anjali Mehta, Nadera Sweiss, and Shiva Shahrara
Treatment of rheumatoid arthritis with marine and botanical oils: an 18-month, randomized, and double-blind trial, George W. Reed, Katherine Leung, Ronald G. Rossetti, Susan Van Buskirk, John T. Sharp, and Robert B. Zurier
Gadolinium-based compounds induce NLRP3-dependent IL-1beta production and peritoneal inflammation, Christian Schmidt-Lauber, Lukas Bossaller, Hani H. Abujudeh, Gregory I. Vladimer, Anette Christ, Katherine A. Fitzgerald, Eicke Latz, Ellen M. Gravallese, Ann Marshak-Rothstein, and Jonathan Kay
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN), Joachim Sieper, Jurgen Braun, Jonathan Kay, Salvatore Badalamenti, Allen R. Radin, Lixia Jiao, Stefano Fiore, Tanya Momtahen, George D. Yancopoulos, Neil Stahl, and Robert D. Inman
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study, Josef S. Smolen, Jonathan Kay, Eric L. Matteson, Robert Landewe, Elizabeth C. Hsia, Stephen Xu, Yiying Zhou, and Mittie K. Doyle
Publications from 2013
Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009, Maryam M. Asgari, Jashin J. Wu, Joel M. Gelfand, Craig Salman, Jeffrey R. Curtis, Leslie R. Harrold, and Lisa J. Herrinton
Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus, Lukas Bossaller, Vijay A. K. Rathinam, Ramon Bonegio, Ping-I Chang, Patricia Busto, Adam R. Wespiser, Daniel R. Caffrey, Quan-Zhen Li, Chandra Mohan, Katherine A. Fitzgerald, Eicke Latz, and Ann Marshak-Rothstein
Relapsing polychondritis, Ratnesh Chopra, Nida Cahudhary, and Jonathan Kay
The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis, Daniel E. Furst, Jonathan Kay, Mary Chester Wasko, Edward Keystone, Arthur Kavanaugh, Atul Deodhar, Frederick T. Murphy, Jeanette H. Magnus, Elizabeth C. Hsia, Benjamin Hsu, Stephen Xu, Mahboob U. Rahman, and Mittie K. Doyle
New developments in gout, Leslie R. Harrold
Cost-related Medication Nonadherence in Older Patients with Rheumatoid Arthritis, Leslie R. Harrold, Becky A. Briesacher, Daniel J. Peterson, Ashley J. Beard, Jeanne M. Madden, Fang Zhang, Jerry H. Gurwitz, and Stephen B. Soumerai
Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire, Leslie R. Harrold, Kathleen M. Mazor, Amarie Negron, Jessica Ogarek, Cassandra L. Firneno, and Robert A. Yood
Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009, Leslie R. Harrold, Craig Salman, Stanford Shoor, Jeffrey R. Curtis, Maryam M. Asgari, Joel M. Gelfand, Jashin J. Wu, and Lisa J. Herrinton
Association between anti-TNF-alpha therapy and interstitial lung disease, Lisa J. Herrinton, Leslie R. Harrold, Liyan Liu, Marsha A. Raebel, Ananse Taharka, Kevin L. Winthrop, Daniel H. Solomon, Jeffrey R. Curtis, James D. Lewis, and Kenneth G. Saag
Rheumatic rarities. Preface, Jonathan Kay
Rheumatoid arthritis: Erosion defined: back to basics, Jonathan Kay and Ellen M. Gravallese
Biosimilars to treat inflammatory arthritis: the challenge of proving identity, Jonathan Kay and Josef S. Smolen
Fibrosis-Associated Single-Nucleotide Polymorphisms in TGFB1 and CAV1 Are Not Associated With the Development of Nephrogenic Systemic Fibrosis, Long P. Le, Lilit Garibyan, Daniel Lara, Karin E. Finberg, A. John Iafrate, Lyn M. Duncan, Jonathan Kay, and Rosalynn M. Nazarian
Validation of a screening instrument for nephrogenic systemic fibrosis, Xinaida Taligare Lima, Maria Beatrice Alora-Palli, Alexandra Boer Kimball, and Jonathan Kay
The role of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells, Kerstin Nundel, Patricia Busto, Michelle E. Debatis, and Ann Marshak-Rothstein
A Delphi Exercise to Identify Characteristic Features of Gout -- Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria, Rebecca L. Prowse and Leslie R. Harrold
Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database, Daniel Schneeberger, Alan Tyndall, Jonathan Kay, Klaus H. Sondergaard, Patricia E. Carreira, Ewa Morgiel, Katrin Deuschle, Chris T. Derk, Malgorzata Widuchowska, and Ulrich A. Walker
Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist, Daniel H. Solomon, Jeremy A. Rassen, Bindee Kuriya, Lang Chen, Leslie R. Harrold, David J. Graham, James D. Lewis, Joyce Lii, Liyan Liu, Marie R. Griffin, and Jeffrey R. Curtis
Rituximab biosimilars, Edward M. Vital, Jonathan Kay, and Paul Emery
Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL, Nicole C. Walsh, K. A. Alexander, Catherine A. Manning, S. K. Karmakar, J. F. Wang, C. M. Weyand, Allison R. Pettit, and Ellen M. Gravallese
Publications from 2012
A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data, Susan E. Andrade, Leslie R. Harrold, Jennifer Tjia, Sarah L. Cutrona, Jane S. Saczynski, Katherine S. Dodd, Robert J. Goldberg, and Jerry H. Gurwitz
Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure, Elana J. Bernstein, Christian Schmidt-Lauber, and Jonathan Kay
Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment, Timothy Beukelman, Fenglong Xie, Lang Chen, John W. Baddley, Elizabeth Delzell, Carlos G. Grijalva, James D. Lewis, Rita Ouellet-Hellstrom, Nivedita M. Patkar, Kenneth G. Saag, Kevin L. Winthrop, Jeffrey R. Curtis, SABER Collaboration, and Leslie R. Harrold
Cutting Edge: FAS (CD95) mediates noncanonical IL-1beta and IL-18 maturation via caspase-8 in an RIP3-independent manner, Lukas Bossaller, Ping-I Chang, Christian Schmidt-Lauber, Sandhya Ganesan, William J. Kaiser, Vijay A. K. Rathinam, Edward S. Mocarski, Deepa Subramanian, Douglas R. Green, Neal S. Silverman, Katherine A. Fitzgerald, Ann Marshak-Rothstein, and Eicke Latz
Identifying patients with osteoporosis or at risk for osteoporotic fractures, Yong Chen, Leslie R. Harrold, Robert A. Yood, Terry S. Field, and Becky A. Briesacher
Malignancy validation in a United States registry of rheumatoid arthritis patients, Mark C. Fisher, Victoria Furer, Marc C. Hochberg, Jeffrey D. Greenberg, Joel M. Kremer, Jeffrey R. Curtis, George W. Reed, Leslie R. Harrold, and Daniel H. Solomon
Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the ACR treatment recommendations, Leslie R. Harrold, Jeffrey R. Curtis, Daniel E. Furst, Mary Jane Bentley, Ying Shan, George W. Reed, Joel Kremer, and Jeffrey D. Greenberg
Patients' knowledge and beliefs concerning gout and its treatment: a population based study, Leslie R. Harrold, Kathleen M. Mazor, Daniel J. Peterson, Nausheen Naz, Cassandra L. Firneno, and Robert A. Yood
Time trends in medication use and expenditures in older patients with rheumatoid arthritis, Leslie R. Harrold, Daniel J. Peterson, Ashley J. Beard, Jerry H. Gurwitz, and Becky A. Briesacher
Association between anti-TNF-alpha therapy and all-cause mortality, Lisa J. Herrinton, Liyan Liu, Lang Chen, Leslie R. Harrold, Marsha A. Raebel, Jeffrey R. Curtis, Marie R. Griffin, Daniel H. Solomon, Kenneth G. Saag, and James D. Lewis
Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012, Jonathan Kay, Brian G. Feagan, Micheal S. Guirguis, Edward C. Keystone, Agnes V. Klein, Anthony S. Lubiniecki, Diane R. Mould, Kwasi A. Nyarko, Anthony A. G. Ridgway, Maureen E. Trudeau, and Jian Wang
ACR/EULAR 2010 rheumatoid arthritis classification criteria, Jonathan Kay and Katherine S. Upchurch
Sensorineural hearing loss following imatinib (Gleevec) administration, Harrison W. Lin, Daniel S. Roberts, Jonathan Kay, and Konstantina M. Stankovic
The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review, Alan M. Rathbun, George W. Reed, and Leslie R. Harrold
The advent of biosimilar therapies in rheumatology--"O brave new world", Morton A. Scheinberg and Jonathan Kay